{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T05:19:31Z","timestamp":1693977571991},"reference-count":30,"publisher":"Japanese Society of Veterinary Science","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Veterinary Medical Science","J. Vet. Med. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1292\/jvms.18-0119","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T22:10:04Z","timestamp":1523311804000},"page":"878-885","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model"],"prefix":"10.1292","volume":"80","author":[{"given":"Yasufumi","family":"TORINIWA","sequence":"first","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"SAITO","sequence":"additional","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"MIYAJIMA","sequence":"additional","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"},{"name":"Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"ISHII","sequence":"additional","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinuko","family":"UNO","sequence":"additional","affiliation":[{"name":"Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"MAEKAWA","sequence":"additional","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"MATSUI","sequence":"additional","affiliation":[{"name":"Kyoto University, Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto 606-8502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"KUME","sequence":"additional","affiliation":[{"name":"Kyoto University, Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto 606-8502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"YAMADA","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Genetics, Graduate School of Science and Technology, Niigata University, 2-8050 Ikarashi, Nishi-ku, Niigata 950-2181, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"OHTA","sequence":"additional","affiliation":[{"name":"Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Day, C. P. and James, O. F. 1998. Steatohepatitis: a tale of two \u201chits\u201d? <i>Gastroenterology<\/i> 114: 842\u2013845.","DOI":"10.1016\/S0016-5085(98)70599-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. de Alwis, N. M. and Day, C. P. 2008. Non-alcoholic fatty liver disease: the mist gradually clears. <i>J. Hepatol.<\/i> 48 Suppl 1: S104\u2013S112.","DOI":"10.1016\/j.jhep.2008.01.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ertle, J., Dech\u00eane, A., Sowa, J. P., Penndorf, V., Herzer, K., Kaiser, G., Schlaak, J. F., Gerken, G., Syn, W. K. and Canbay, A. 2011. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. <i>Int. J. Cancer<\/i> 128: 2436\u20132443.","DOI":"10.1002\/ijc.25797"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fukunishi, S., Nishio, H., Fukuda, A., Takeshita, A., Hanafusa, T., Higuchi, K. and Suzuki, K. 2009. Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa\/fa) Rats. <i>J. Clin. Biochem. Nutr.<\/i> 45: 322\u2013328.","DOI":"10.3164\/jcbn.09-50"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gastaldelli, A., Harrison, S. A., Belfort-Aguilar, R., Hardies, L. J., Balas, B., Schenker, S. and Cusi, K. 2009. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. <i>Hepatology<\/i> 50: 1087\u20131093.","DOI":"10.1002\/hep.23116"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. He, L., Liu, X., Wang, L. and Yang, Z. 2016. Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. <i>Medicine (Baltimore)<\/i> 95: e4947.","DOI":"10.1097\/MD.0000000000004947"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ichimura, M., Kawase, M., Masuzumi, M., Sakaki, M., Nagata, Y., Tanaka, K., Suruga, K., Tamaru, S., Kato, S., Tsuneyama, K. and Omagari, K. 2015. High-fat and high-cholesterol diet rapidly induces non-alcoholic steatohepatitis with advanced fibrosis in Sprague-Dawley rats. <i>Hepatol. Res.<\/i> 45: 458\u2013469.","DOI":"10.1111\/hepr.12358"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ishii, Y., Motohashi, Y., Muramatsu, M., Katsuda, Y., Miyajima, K., Sasase, T., Yamada, T., Matsui, T., Kume, S. and Ohta, T. 2015. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions. <i>World J. Gastroenterol.<\/i> 21: 9067\u20139078.","DOI":"10.3748\/wjg.v21.i30.9067"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishii, Y., Ohta, T., Sasase, T., Morinaga, H., Ueda, N., Hata, T., Kakutani, M., Miyajima, K., Katsuda, Y., Masuyama, T., Shinohara, M. and Matsushita, M. 2010. Pathophysiological analysis of female Spontaneously Diabetic Torii fatty rats. <i>Exp. Anim.<\/i> 59: 73\u201384.","DOI":"10.1538\/expanim.59.73"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ito, M., Suzuki, J., Sasaki, M., Watanabe, K., Tsujioka, S., Takahashi, Y., Gomori, A., Hirose, H., Ishihara, A., Iwaasa, H. and Kanatani, A. 2006. Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice. <i>Hepatol. Res.<\/i> 34: 92\u201398.","DOI":"10.1016\/j.hepres.2005.12.001"},{"key":"11","unstructured":"11. Karim, M. F., Al-Mahtab, M., Rahman, S. and Debnath, C. R. 2015. Non-alcoholic Fatty Liver Disease (NAFLD)--A Review. <i>Mymensingh Med. J.<\/i> 24: 873\u2013880."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Katsuda, Y., Ohta, T., Miyajima, K., Kemmochi, Y., Sasase, T., Tong, B., Shinohara, M. and Yamada, T. 2014. Diabetic complications in obese type 2 diabetic rat models. <i>Exp. Anim.<\/i> 63: 121\u2013132.","DOI":"10.1538\/expanim.63.121"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kawai, D., Takaki, A., Nakatsuka, A., Wada, J., Tamaki, N., Yasunaka, T., Koike, K., Tsuzaki, R., Matsumoto, K., Miyake, Y., Shiraha, H., Morita, M., Makino, H. and Yamamoto, K. 2012. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. <i>Hepatology<\/i> 56: 912\u2013921.","DOI":"10.1002\/hep.25782"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lebovitz, H. E. and Banerji, M. A. 2001. Insulin resistance and its treatment by thiazolidinediones. <i>Recent Prog. Horm. Res.<\/i> 56: 265\u2013294.","DOI":"10.1210\/rp.56.1.265"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Leclercq, I. A., Lebrun, V. A., St\u00e4rkel, P. and Horsmans, Y. J. 2007. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. <i>Lab. Invest.<\/i> 87: 56\u201365.","DOI":"10.1038\/labinvest.3700489"},{"key":"16","unstructured":"16. Link, J. T. 2003. Pharmacological regulation of hepatic glucose production. <i>Curr. Opin. Investig. Drugs<\/i> 4: 421\u2013429."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lin, M., Zhao, S., Shen, L. and Xu, D. 2014. Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition. <i>Drug Saf.<\/i> 37: 213\u2013224.","DOI":"10.1007\/s40264-014-0147-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Li, Y., Liu, L., Wang, B., Wang, J. and Chen, D. 2013. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. <i>Biomed. Rep.<\/i> 1: 57\u201364.","DOI":"10.3892\/br.2012.18"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lomonaco, R., Sunny, N. E., Bril, F. and Cusi, K. 2013. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. <i>Drugs<\/i> 73: 1\u201314.","DOI":"10.1007\/s40265-012-0004-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Loomba, R., Lutchman, G., Kleiner, D. E., Ricks, M., Feld, J. J., Borg, B. B., Modi, A., Nagabhyru, P., Sumner, A. E., Liang, T. J. and Hoofnagle, J. H. 2009. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. <i>Aliment. Pharmacol. Ther.<\/i> 29: 172\u2013182.","DOI":"10.1111\/j.1365-2036.2008.03869.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Malik, S. M., Gupte, P. A., de Vera, M. E. and Ahmad, J. 2009. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. <i>Clin. Gastroenterol. Hepatol.<\/i> 7: 800\u2013806.","DOI":"10.1016\/j.cgh.2009.02.025"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Masuyama, T., Katsuda, Y. and Shinohara, M. 2005. A novel model of obesity-related diabetes: introgression of the Lepr(fa) allele of the Zucker fatty rat into nonobese Spontaneously Diabetic Torii (SDT) rats. <i>Exp. Anim.<\/i> 54: 13\u201320.","DOI":"10.1538\/expanim.54.13"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Matsui, K., Ohta, T., Oda, T., Sasase, T., Ueda, N., Miyajima, K., Masuyama, T., Shinohara, M. and Matsushita, M. 2008. Diabetes-associated complications in Spontaneously Diabetic Torii fatty rats. <i>Exp. Anim.<\/i> 57: 111\u2013121.","DOI":"10.1538\/expanim.57.111"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Neuschwander-Tetri, B. A. 2010. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. <i>Hepatology<\/i> 52: 774\u2013788.","DOI":"10.1002\/hep.23719"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Oseini, A. M. and Sanyal, A. J. 2017. Therapies in non-alcoholic steatohepatitis (NASH). <i>Liver Int.<\/i> 37 Suppl 1: 97\u2013103.","DOI":"10.1111\/liv.13302"},{"key":"26","unstructured":"26. Pettinelli, P., Obreg\u00f3n, A. M. and Videla, L. A. 2011. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. <i>Nutr. Hosp.<\/i> 26: 441\u2013450."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sanyal, A. J., Friedman, S. L., McCullough, A. J.,A. J.,Dimick-Santos, L. and American Association for the Study of Liver Diseases United States Food and Drug Administration. 2015. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. <i>Hepatology<\/i> 61: 1392\u2013405.","DOI":"10.1002\/hep.27678"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takaki, A., Kawai, D. and Yamamoto, K. 2013. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). <i>Int. J. Mol. Sci.<\/i> 14: 20704\u201320728.","DOI":"10.3390\/ijms141020704"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Toriniwa, Y., Muramatsu, M., Ishii, Y., Riya, E., Miyajima, K., Ohshida, S., Kitatani, K., Takekoshi, S., Matsui, T., Kume, S., Yamada, T. and Ohta, T. 2018. Pathophysiological Characteristics of Non-Alcoholic Steatohepatitis-like Changes in Cholesterol-Loaded Type 2 Diabetic Rats. <i>Physiol. Res.<\/i> (in press).","DOI":"10.33549\/physiolres.933784"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Xu, H., Zhou, Y., Liu, Y., Ping, J., Shou, Q., Chen, F. and Ruo, R. 2016. Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis. <i>J. Endocrinol.<\/i> 229: 133\u2013144.","DOI":"10.1530\/JOE-15-0409"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/80\/6\/80_18-0119\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T20:21:31Z","timestamp":1571084491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/80\/6\/80_18-0119\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.18-0119","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}